VERTEX PHARMACEUTICALS INC (VRTX) Institutional Ownership and Insiders Activity
VERTEX PHARMACEUTICALS INC (VRTX) is widely held by institutional investors, with 1731 firms reporting positions valued at approximately $117.02B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Capital World Investors is the largest disclosed holder, reporting approximately $12.97B in VRTX holdings in its latest filing.
Recent insider activity includes 5 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
1,731
Total Reported Value
$117.02B
Largest Holder
Capital World Investors
Largest Position
$12.97B
Insider Transactions (90d)
5
Latest Filing Quarter
Q3 2026
New Institutional Positions
0
Funds Exiting Positions
1,697
Top Institutional Owners
View all- Capital World Investors$12.97B
- Blackrock, Inc.$11.98B
- Capital Research Global Investors$9.68B
- Vanguard Capital Management Llc$8.24B
- State Street Corp$5.90B
VRTX News
All news- Provident Investment Management Portfolio Changes in Q2 2026
Aug 12, 2026 · valut.ai
- Andrew Hill Investment Advisors Q2 2026 Portfolio Activity: Concentrated Buys and Strategic Sells
Jul 17, 2026 · valut.ai
Related VRTX Institutional Insights:
- VRTX 13F Institutional Holders
- VRTX Top Institutional Shareholders
- VRTX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- VRTX Insider Trading & SEC Form 4 Activity
- VRTX Articles
- Top Institutional Investor Stock Rankings